# NRSN2

## Overview
NRSN2 is a gene that encodes the protein neurensin 2, which is primarily involved in neuronal functions, particularly in intracellular vesicle trafficking and membrane dynamics. Neurensin 2 is categorized as a neuronal protein and is predominantly expressed in the nervous system, where it plays a critical role in the transport and localization of synaptic components. It is notably active in GABAergic interneurons within the hippocampus, influencing AMPA receptor signaling and synaptic plasticity. Beyond its neurological roles, NRSN2 is implicated in various cellular signaling pathways, including the PI3K/AKT/mTOR and NF-κB pathways, which are significant in cancer biology. The gene's expression levels have been associated with different cancer types, acting as either a tumor promoter or suppressor depending on the context. Additionally, NRSN2 has been linked to emotional behavior and stress responses, suggesting its involvement in neuropsychiatric disorders (Umschweif2021Identification; Wang2015DownRegulated; Nakanishi2006Molecular).

## Function
Neurensin-2 (NRSN2) is a neuronal protein involved in intracellular vesicle trafficking and membrane dynamics, primarily active in the nervous system. It is associated with endosomes and postsynaptic proteins, playing a crucial role in the transport and localization of synaptic components. Neurensin-2 is highly expressed in subpopulations of GABAergic interneurons in the hippocampus, where it modulates AMPA receptor (AMPAR) signaling. It binds to postsynaptic proteins and is involved in the endocytosis of these proteins, affecting the subcellular localization of postsynaptic AMPARs (Umschweif2021Identification).

Neurensin-2 interacts with Homer scaffold proteins and is incorporated into endocytic vesicles, influencing excitatory synapses and emotional behavior by regulating AMPAR signaling. In Neurensin-2 knockout mice, increased levels of AMPA2 and Homer1 proteins are observed, indicating its role in modulating synaptic plasticity (Umschweif2021Identification). The protein is localized in small vesicles within neural cells, including lysosomes in the perinuclear region, suggesting a role in vesicle transport and maintenance (Nakanishi2006Molecular).

Neurensin-2's expression is regulated by SMARCA3, a chromatin remodeler, which represses its expression in hippocampal interneurons, thereby influencing emotional behavior and stress responses (Umschweif2021Identification).

## Clinical Significance
Alterations in the expression of the NRSN2 gene have been implicated in various cancers. In breast cancer, NRSN2 expression is elevated, promoting cancer progression by enhancing cell proliferation, migration, and invasion through the activation of the PI3K/AKT/mTOR and NF-κB signaling pathways. Knockdown of NRSN2 in breast cancer models results in reduced tumor growth, suggesting its potential as a therapeutic target (Ren2019NRSN2).

In contrast, NRSN2 acts as a tumor suppressor in hepatocellular carcinoma (HCC), where its expression is significantly down-regulated. This down-regulation is associated with larger tumor size and advanced disease stage. Patients with higher NRSN2 expression have better survival rates, indicating its potential as a prognostic marker. The gene influences cell proliferation and survival through the PI3K/AKT/mTOR pathway (Wang2015DownRegulated).

In ovarian cancer, NRSN2 is up-regulated and associated with a malignant phenotype, enhancing cell proliferation, invasion, and chemoresistance. It is involved in the Wnt/b-catenin signaling pathway and correlates with cancer stem cell markers, suggesting a role in maintaining cancer cell stemness (Tang2017Highly).

NRSN2 also plays a role in emotional behavior, with its upregulation linked to depressive-like behaviors in mice. Knockout models show resilience to stress, indicating its potential involvement in neuropsychiatric disorders (Umschweif2021Identification).

## Interactions
Neurensin-2 (NRSN2) is involved in various protein interactions that influence cellular signaling pathways. In the context of neuronal function, NRSN2 binds to postsynaptic proteins and regulates AMPAR signaling. It interacts with Homer scaffold proteins, specifically Homer1 and Homer3, and is incorporated into endocytic vesicles, interacting with proteins such as the clathrin heavy chain and VPS37b. NRSN2 also binds directly to Homer3 and Arpc1b, suggesting a role in endocytosis and postsynaptic signaling (Umschweif2021Identification).

In cancer biology, NRSN2 is implicated in the activation of the PI3K/AKT/mTOR signaling pathway, which is crucial for cell survival and proliferation. In hepatocellular carcinoma, silencing NRSN2 activates this pathway, leading to increased cell viability and reduced apoptosis (Wang2015DownRegulated). In breast cancer, NRSN2 overexpression activates both the PI3K/AKT/mTOR and NF-κB signaling pathways, promoting cell proliferation and migration (Ren2019NRSN2). These interactions highlight NRSN2's role in modulating key signaling pathways across different cellular contexts.


## References


[1. (Ren2019NRSN2) Fei Ren, Wei Zhang, Shuai Lu, Hong Ren, and Yantong Guo. Nrsn2 promotes breast cancer metastasis by activating pi3k/akt/mtor and nf‑κb signaling pathways. Oncology Letters, November 2019. URL: http://dx.doi.org/10.3892/ol.2019.11152, doi:10.3892/ol.2019.11152. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.11152)

[2. (Tang2017Highly) Wenbin Tang, Aimin Ren, Hongyang Xiao, Huizhen Sun, and Bin Li. Highly expressed nrsn2 is related to malignant phenotype in ovarian cancer. Biomedicine &amp; Pharmacotherapy, 85:248–255, January 2017. URL: http://dx.doi.org/10.1016/j.biopha.2016.11.012, doi:10.1016/j.biopha.2016.11.012. This article has 7 citations.](https://doi.org/10.1016/j.biopha.2016.11.012)

[3. (Nakanishi2006Molecular) Katsuyuki Nakanishi, Mizuho Ida, Haruno Suzuki, Chiaki Kitano, Akitsugu Yamamoto, Nozomu Mori, Masasuke Araki, and Shigeru Taketani. Molecular characterization of a transport vesicle protein neurensin-2, a homologue of neurensin-1, expressed in neural cells. Brain Research, 1081(1):1–8, April 2006. URL: http://dx.doi.org/10.1016/j.brainres.2006.01.085, doi:10.1016/j.brainres.2006.01.085. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2006.01.085)

[4. (Umschweif2021Identification) Gali Umschweif, Lucian Medrihan, Andrés Guillén-Samander, Wei Wang, Yotam Sagi, and Paul Greengard. Identification of neurensin-2 as a novel modulator of emotional behavior. Molecular Psychiatry, 26(7):2872–2885, March 2021. URL: http://dx.doi.org/10.1038/s41380-021-01058-5, doi:10.1038/s41380-021-01058-5. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-021-01058-5)

[5. (Wang2015DownRegulated) Xin Wang, Longzhi Han, Jianjun Zhang, and Qiang Xia. Down-regulated nrsn2 promotes cell proliferation and survival through pi3k/akt/mtor pathway in hepatocellular carcinoma. Digestive Diseases and Sciences, 60(10):3011–3018, June 2015. URL: http://dx.doi.org/10.1007/s10620-015-3736-3, doi:10.1007/s10620-015-3736-3. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10620-015-3736-3)